We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+20.76%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.9B
AUM Growth
+$2.99B
(+30%)
Cap. Flow
+$1.15B
Cap. Flow
% of AUM
8.87%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
2,001
New
167
Increased
892
Reduced
787
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$188M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$143M |
| 3 |
Apple
AAPL
|
+$66.1M |
| 4 |
Amazon
AMZN
|
+$65.5M |
| 5 |
Microsoft
MSFT
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNO Financial Group
CNO
|
+$19.2M |
| 2 |
Gen Digital
GEN
|
+$11.2M |
| 3 |
Reinsurance Group of America
RGA
|
+$10.7M |
| 4 |
RTN
Raytheon Company
RTN
|
+$10.2M |
| 5 |
AES
AES
|
+$8.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.71% |
| 2 | Healthcare | 10.09% |
| 3 | Financials | 7.77% |
| 4 | Consumer Discretionary | 7.59% |
| 5 | Communication Services | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
701
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.16M | 0.02% |
50,114
+11,481
| +30% | +$787K |
|
702
New Mountain Finance
NMFC
$732M
| $3.16M | 0.02% |
340,473
-8,994
| -3% | -$73.9K |
|
703
Hewlett Packard
HPE
$70.5B
| $3.15M | 0.02% |
324,046
+36,086
| +13% | +$354K |
|
704
MarketAxess Holdings
MKTX
$5.72B
| $3.12M | 0.02% |
6,228
+1,922
| +45% | +$895K |
|
705
DaVita
DVA
$11.7B
| $3.11M | 0.02% |
39,341
+3,228
| +9% | +$252K |
|
|
ONC
706
BeOne Medicines Ltd
ONC
$39.4B
| $3.1M | 0.02% |
16,444
+2,453
| +18% | +$399K |
|
707
Iovance Biotherapeutics
IOVA
$2.87B
| $3.09M | 0.02% |
+112,602
| New | +$3.7M |
|
708
Domino's
DPZ
$11.6B
| $3.09M | 0.02% |
8,355
+1,381
| +20% | +$509K |
|
|
FMN
709
Federated Hermes Premier Municipal Income Fund
FMN
$87.5M
| $3.08M | 0.02% |
233,676
+45,954
| +24% | +$604K |
|
|
HBI
710
DELISTED
Hanesbrands
HBI
| $3.07M | 0.02% |
271,964
+27,015
| +11% | +$270K |
|
|
AOD
711
abrdn Total Dynamic Dividend Fund
AOD
$1.12B
| $3.06M | 0.02% |
397,018
-15,226
| -4% | -$111K |
|
712
Atlantic Union Bankshares
AUB
$5.97B
| $3.05M | 0.02% |
131,658
-9,805
| -7% | -$221K |
|
|
WMGI
713
DELISTED
Wright Medical Group Inc
WMGI
| $3.04M | 0.02% |
102,416
+33,361
| +48% | +$976K |
|
714
Deere & Co
DE
$168B
| $3.04M | 0.02% |
19,335
+3,575
| +23% | +$518K |
|
|
PBCT
715
DELISTED
People's United Financial Inc
PBCT
| $3.02M | 0.02% |
261,435
+106,032
| +68% | +$1.23M |
|
716
Loews
L
$23.6B
| $2.98M | 0.02% |
87,021
+5,560
| +7% | +$187K |
|
717
Agios Pharmaceuticals
AGIO
$1.93B
| $2.95M | 0.02% |
55,140
+6,308
| +13% | +$292K |
|
718
Otis Worldwide
OTIS
$28.2B
| $2.95M | 0.02% |
+51,871
| New | +$2.69M |
|
719
BlackRock Multi-Sector Income Trust
BIT
$702M
| $2.94M | 0.02% |
203,773
+9,892
| +5% | +$135K |
|
720
AutoZone
AZO
$51.1B
| $2.94M | 0.02% |
2,603
+1,233
| +90% | +$1.3M |
|
721
Radware
RDWR
$1.19B
| $2.91M | 0.02% |
123,413
+21,579
| +21% | +$495K |
|
722
Park Aerospace
PKE
$819M
| $2.91M | 0.02% |
261,213
-8,943
| -3% | -$111K |
|
723
Cencora
COR
$61.2B
| $2.89M | 0.02% |
28,700
+3,892
| +16% | +$358K |
|
724
Royce Value Trust
RVT
$2.3B
| $2.88M | 0.02% |
230,018
-34,531
| -13% | -$396K |
|
725
State Street SPDR Portfolio TIPS ETF
SPIP
$1B
| $2.87M | 0.02% |
95,272
-10,966
| -10% | -$326K |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
WANY
ACA
ZIG
Guggenheim Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Guggenheim Capital held 2,001 positions worth $12.9B, up 30% from $9.93B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Guggenheim Capital deployed $1.15B of net new capital in Q2 2020, opening 167 new positions and adding to 892 existing holdings. Its largest new stake was SelectQuote: 1,199,960 shares worth $30.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CNO Financial Group, an estimated $19.2M trimmed.
- Guggenheim Capital's largest Q2 2020 buy was SelectQuote: 1,199,960 shares worth $30.4M.
- Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $188M increase.
- Guggenheim Capital's biggest Q2 2020 reduction was CNO Financial Group, cutting an estimated $19.2M.
- Guggenheim Capital fully exited Raytheon Company in Q2 2020, selling an estimated $10.2M.
- Guggenheim Capital's ten largest holdings make up 23% of its $12.9B portfolio in Q2 2020.
- Guggenheim Capital opened 167 new positions and closed 133 in Q2 2020.
- Guggenheim Capital's portfolio value rose 30% quarter-over-quarter to $12.9B.
Based on Guggenheim Capital's 13F filing for Q2 2020, filed 14 Aug 2020.